Bio-Techne (TECH) Share-based Compensation (2009 - 2026)
Bio-Techne's (TECH) quarterly Share-based Compensation came in at $40.8 million in Q1 2026, up 116471.43% year-on-year from N/an in Q1 2025, and up 10838.34% quarter-over-quarter from $373000.0 in Q4 2025.
Bio-Techne (TECH) Share-based Compensation (2009 - 2026) Analysis & Trends
Bio-Techne's Share-based Compensation history runs 18 years deep, the most recent figure standing at $40.8 million for Q1 2026.
- On a quarterly basis, Share-based Compensation rose 116471.43% year-over-year to $40.8 million in Q1 2026; TTM through Mar 2026 was $40.8 million, a 4711.32% increase from a year earlier, with the FY2025 full-year figure at $40.8 million, up 14.06% from the prior year.
- Share-based Compensation climbed to $40.8 million in Q1 2026 per TECH's latest filing, from $373000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $40.8 million in Q1 2026 and bottomed at -$12.4 million in Q2 2023.
- The 5-year median for Share-based Compensation is $113000.0 (2023), against an average of $3.4 million.
- Across the five-year window, Share-based Compensation tumbled 153.99% in 2023 and surged 116471.43% in 2026, its largest moves.
- Year by year, Share-based Compensation stood at $333000.0 in 2022, then rose by 2.1% to $340000.0 in 2023, then climbed by 9.71% to $373000.0 in 2024, then changed by 0.0% to $373000.0 in 2025, then surged by 10838.34% to $40.8 million in 2026.
- Per Business Quant, the three latest TECH Share-based Compensation figures stand at $40.8 million (Q1 2026), $373000.0 (Q4 2025), and -$2000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9.26 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.18 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 87.30 Mn |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn | 40.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.80 Mn |
| Mar 31, 2026 | 40.80 Mn |
| Dec 31, 2025 | 373,000.00 |
| Dec 31, 2025 | 373,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Jun 30, 2025 | 4.55 Mn |
| Jun 30, 2025 | 4.55 Mn |
| Mar 31, 2025 | 35,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | 373,000.00 |
| Dec 31, 2024 | 373,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 402,000.00 |
| Jun 30, 2024 | 402,000.00 |
| Mar 31, 2024 | 80,000.00 |
| Mar 31, 2024 | 80,000.00 |
| Dec 31, 2023 | 340,000.00 |
| Dec 31, 2023 | 340,000.00 |